tiprankstipranks
Trending News
More News >
Jiutian Chemical Group Limited (SG:C8R)
SGX:C8R
Singapore Market

Jiutian Chemical Group Limited (C8R) AI Stock Analysis

Compare
8 Followers

Top Page

SG:C8R

Jiutian Chemical Group Limited

(SGX:C8R)

Select Model
Select Model
Select Model
Neutral 45 (OpenAI - 4o)
Rating:45Neutral
Price Target:
S$0.03
▼(-13.33% Downside)
Jiutian Chemical Group Limited's overall stock score is primarily impacted by its poor financial performance, characterized by declining revenues and negative profitability. While technical analysis shows some positive trends, the valuation remains weak due to a negative P/E ratio and lack of dividend yield. The absence of earnings call data and corporate events leaves these areas unaddressed.
Positive Factors
Strategic Restructuring
The strategic restructuring of HNEC could enhance Jiutian's operational efficiency and market positioning, potentially leading to improved strategic direction and resource allocation.
Leverage Management
Improved leverage management indicates better financial discipline and reduced risk, providing a more stable financial foundation for future growth.
Cash Generation Efficiency
Efficient cash generation relative to net income suggests the company can convert earnings into cash effectively, supporting operational needs and potential investments.
Negative Factors
Declining Revenue
A consistent decline in revenue reflects shrinking market presence and demand, posing a threat to long-term growth and financial stability.
Negative Profit Margins
Negative profit margins indicate the company is unable to cover its costs, which could lead to financial distress if not addressed.
Weak Cash Flow
Weak cash flow limits the company's ability to fund operations and invest in growth, potentially leading to liquidity issues.

Jiutian Chemical Group Limited (C8R) vs. iShares MSCI Singapore ETF (EWS)

Jiutian Chemical Group Limited Business Overview & Revenue Model

Company DescriptionJiutian Chemical Group Limited, an investment holding company, manufactures and sells chemical-based products in the People's Republic of China. The company offers dimethylformamide, which is used as a feedstock in the production of polyurethane, pharmaceutical, and agro chemical products, as well as an absorbing agent primarily in electronics, acrylic fibers, and pharmaceutical products; and methylamine, a chemical feedstock in the organic chemical industry used in various areas, such as agricultural chemicals, medicines, fuels, synthetic resins, and leather making, as well as in the production of the solvent used for chemical fibers, activating agents, and photography. It also provides sodium hydrosulfite, a crystalline powder for use in water treatment, gas purification, cleaning, and stripping, as well as in the industrial processing of textiles, leather, foods, polymers, photography, and others; industrial and consumable carbon dioxide for use in aerated beverages, tobacco, and preserving vegetables; Oxygen-18, an isotope of oxygen to produce fluorodeoxyglucose; deuterium depleted water to inhibit cancer growth; and industrial methanol. In addition, the company is involved in the sale of downstream products; and research and development of isotope technology. Jiutian Chemical Group Limited was founded in 1994 and is based in Singapore.
How the Company Makes MoneyJiutian Chemical Group Limited generates revenue through multiple streams, primarily by manufacturing and selling its chemical products to various industries. The company's revenue model is based on the volume of chemicals produced and sold, as well as the pricing strategies employed for different product lines. Key revenue streams include direct sales to manufacturers in sectors like agriculture, automotive, and construction. Additionally, Jiutian may engage in long-term contracts with major clients, providing a steady income flow. The company also benefits from strategic partnerships with distributors and suppliers, enhancing its market reach and operational efficiency. Factors contributing to its earnings include fluctuations in raw material prices, demand for specialty chemicals, and the overall health of the global chemical market.

Jiutian Chemical Group Limited Financial Statement Overview

Summary
Jiutian Chemical Group Limited is facing significant financial challenges, with declining revenues, negative profitability margins, and weak cash flow generation. While the balance sheet shows some improvement in leverage, the overall financial health is compromised by poor operational performance and cash flow issues.
Income Statement
30
Negative
Jiutian Chemical Group Limited has experienced a significant decline in revenue and profitability over recent years. The gross profit margin and net profit margin have turned negative, indicating the company is struggling to cover its costs. The revenue growth rate has also been negative, reflecting a shrinking top line. These factors suggest financial instability and operational challenges.
Balance Sheet
40
Negative
The company's balance sheet shows a moderate debt-to-equity ratio, which has improved over the years, indicating better leverage management. However, the return on equity has been negative recently, reflecting poor profitability. The equity ratio is relatively stable, suggesting a balanced asset structure, but the overall financial health is weakened by declining equity returns.
Cash Flow
35
Negative
Cash flow metrics reveal a challenging situation with negative operating cash flow and free cash flow. Although there is a positive free cash flow to net income ratio, indicating some efficiency in cash generation relative to net income, the overall cash flow position is concerning due to negative growth and coverage ratios.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue393.13M243.76M598.56M2.43B2.17B1.15B
Gross Profit-147.20M-82.26M-260.18M708.41M675.62M274.77M
EBITDA-141.98M-118.22M-321.76M696.61M517.79M274.66M
Net Income-162.31M-147.80M-344.64M490.50M324.90M173.69M
Balance Sheet
Total Assets1.42B1.05B1.29B1.99B1.89B1.43B
Cash, Cash Equivalents and Short-Term Investments698.48M400.41M529.62M1.11B773.55M259.73M
Total Debt234.88M289.32M265.88M134.64M228.18M344.30M
Total Liabilities469.16M427.02M523.23M764.65M1.08B911.93M
Stockholders Equity948.17M618.04M765.84M1.22B816.21M524.74M
Cash Flow
Free Cash Flow-356.18M-171.63M-511.23M424.05M633.54M122.69M
Operating Cash Flow-328.39M-81.58M-385.65M434.01M655.81M129.02M
Investing Cash Flow-27.72M-89.54M-125.70M-9.85M-27.68M-10.90M
Financing Cash Flow-53.04M32.87M-732.00K-95.52M-110.89M5.67M

Jiutian Chemical Group Limited Technical Analysis

Technical Analysis Sentiment
Positive
Last Price0.03
Price Trends
50DMA
0.03
Positive
100DMA
0.03
Positive
200DMA
0.03
Positive
Market Momentum
MACD
>-0.01
Negative
RSI
52.21
Neutral
STOCH
300.00
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SG:C8R, the sentiment is Positive. The current price of 0.03 is above the 20-day moving average (MA) of 0.03, above the 50-day MA of 0.03, and above the 200-day MA of 0.03, indicating a bullish trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 52.21 is Neutral, neither overbought nor oversold. The STOCH value of 300.00 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for SG:C8R.

Jiutian Chemical Group Limited Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
61
Neutral
$10.43B7.12-0.05%2.87%2.86%-36.73%
46
Neutral
S$41.39M-1.78-19.55%0.92%-7.45%-480.22%
45
Neutral
S$51.70M-2.20-20.85%-2.43%52.80%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
SG:C8R
Jiutian Chemical Group Limited
0.03
0.00
0.00%
SG:C05
Chemical Industries Far East Ltd.
0.54
0.08
17.39%
SG:5DS
MegaChem Ltd.
0.44
0.02
4.76%
SG:A55
Asia Enterprises Holding Ltd.
0.16
0.04
33.33%
SG:BEI
LHT Holdings Ltd
0.90
0.06
7.14%
SG:Y8E
Samurai 2K Aerosol Ltd.
0.12
0.06
100.00%

Jiutian Chemical Group Limited Corporate Events

Jiutian Chemical Group Sees Revenue Surge Amid Strategic Production Halts
Nov 11, 2025

Jiutian Chemical Group Limited reported a 217% increase in revenue for the third quarter of 2025 compared to the same period in 2024, driven by higher chemical trading activities. Despite a net loss of RMB 30.34 million, the company showed improvement from the previous year’s loss, attributing this to strategic production halts and cost-control measures. The company remains focused on operational efficiency and financial discipline to seize future growth opportunities amid challenging market conditions.

Jiutian Chemical’s Controlling Shareholder to Undergo Strategic Restructuring
Sep 25, 2025

Jiutian Chemical Group Limited has announced that its ultimate controlling shareholder, Henan Energy and Chemical Industry Group Co., Ltd. (HNEC), will undergo a strategic restructuring. This restructuring, decided by the State-owned Assets Supervision and Administration Commission of Henan Province, could impact the company’s operations and market positioning, as HNEC holds a significant share in Jiutian through its subsidiaries.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Oct 29, 2025